Bank of America (BAC) Q3 2026 Earnings: Regulatory Charge Weighs on Results Despite 8% NII Growth
Key Takeaways
- Bank of America reported third-quarter 2026 net income of $6.9 billion, or $0.91 per diluted share, down from $8.3 billion and $1.04 a year earlier.
- Results included a $1.2 billion regulatory settlement charge (about $0.17 per share); excluding it, adjusted earnings were roughly $1.08 per share, slightly below analyst consensus.
- Revenue, net of interest expense, rose 3% year over year to $30.0 billion, while net interest income (NII) climbed 8% to about $16.4 billion.
- Weaker investment banking fees (down 11%) and a decline in fixed-income trading weighed on results, even as consumer banking and wealth management stayed resilient.
- Bank of America returned $8.3 billion to shareholders through dividends and buybacks and reiterated a positive NII outlook for 2027.
Why Bank of America’s Results Matter Right Now
As the second-largest U.S. bank by assets, Bank of America (BAC) serves as a useful bellwether for consumer health, credit conditions, and capital-markets activity. Its third-quarter report arrives at a time when investors are balancing resilient consumer spending against softer trading and deal-making volumes, along with ongoing interest-rate sensitivity. Because the bank’s results span consumer banking, wealth management, global banking, and global markets, this quarter provides a broad snapshot of the U.S. economy. The headline numbers were affected by a one-time regulatory charge tied to anti-money-laundering compliance, so the underlying adjusted performance deserves particular attention when assessing core earnings power.
Breaking Down the Reported Numbers
Bank of America (BAC) reported net income of $6.9 billion, or $0.91 per diluted share, for the third quarter of 2026, down from $8.3 billion and $1.04 per share in the prior-year period. The decline reflected a $1.2 billion regulatory settlement charge, which reduced earnings per share by about $0.17. Excluding that charge, adjusted net income was roughly $8.1 billion, or about $1.08 per share — slightly below the FactSet consensus estimate of about $1.10. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Total revenue, net of interest expense, increased 3% year over year to $30.0 billion, narrowly missing Wall Street’s estimate of roughly $30.6 billion. The bank’s core lending engine remained a bright spot: net interest income rose 8% to about $16.4 billion, helped by loan growth, deposit growth, and fixed-rate asset repricing. Offsetting this, investment banking fees fell 11% to $1.8 billion, and fixed income, currencies, and commodities trading revenue declined amid reduced client activity, even as equities delivered a record third quarter.
Noninterest expense climbed to $19.7 billion, including the settlement charge; excluding it, adjusted expenses were about $18.5 billion, up roughly 7%. The efficiency ratio rose to 66% (62% adjusted). Provision for credit losses held steady at $1.3 billion, while the Common Equity Tier 1 capital ratio stood at 10.9%, well above regulatory minimums.
How the Market Reacted
Bank of America (BAC) shares fell more than 5% in premarket trading following the report, as the regulatory charge and softer capital-markets revenue overshadowed solid core performance. Investors appeared to focus on the earnings miss and the one-time settlement, even as management emphasized that the bank’s consumer, wealth, and commercial businesses continued to show strength. The reaction also reflected concern over weaker fixed-income trading and investment banking fees, alongside a modest decline in the CET1 ratio. Sentiment was tempered by signs of resilience — including 8% NII growth and $8.3 billion in capital returned to shareholders — but the near-term narrative centered on the settlement’s impact and softer market-sensitive revenues.
Forward Outlook and Key Factors to Monitor
Looking ahead, management struck an optimistic tone on net interest income, expecting NII to improve sequentially in the fourth quarter and again through 2027. The bank reaffirmed full-year 2026 NII growth guidance of approximately 8% and projected 2027 growth of 8% or more, an outlook that assumes three 25-basis-point interest-rate increases through June 2027. Investors will be watching whether that guidance holds if the rate path shifts.
Several factors deserve close attention. First, expense discipline remains key, as adjusted expenses rose about 7% year over year on higher revenue-related costs and continued investment in technology and artificial intelligence. Management has signaled that positive operating leverage should return in the fourth quarter. Second, the investment banking pipeline is reportedly strong, and any pickup in deal activity could lift fee revenue. Third, credit quality remains a focal point, with net charge-offs and the provision for credit losses holding steady and asset quality continuing to improve.
Finally, regulatory and compliance matters will stay in focus following the settlement, including the pace of remediation work and any associated costs. Together, these dynamics will shape how investors evaluate Bank of America’s earnings trajectory heading into 2027.
Using AI Tools to Analyze Earnings Reports
When reviewing quarterly results like these, I often turn to Tickeron’s AI Screener to quickly filter financial stocks by key metrics and spot comparable patterns across the sector. It helps me cross-check momentum signals and industry trends without spending hours on manual screening. The tool has become a regular part of my process for earnings season.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
BAC sees MACD Histogram crosses below signal line
BAC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 14, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 32 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 67%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BAC as a result. In 43 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.
BAC moved below its 50-day moving average on September 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BAC crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 58%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
The Aroon Indicator for BAC entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for BAC's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 35 of 52 cases where BAC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
Following a +1.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAC advanced for three days, in 213 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
BAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 2 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 55 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 21, placing this stock slightly worse than average.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. BAC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.405) is normal, around the industry mean (1.866). P/E Ratio (12.811) is within average values for comparable stocks, (14.888). Projected Growth (PEG Ratio) (0.873) is also within normal values, averaging (2.139). Dividend Yield (0.021) settles around the average of (0.026) among similar stocks. P/S Ratio (3.643) is also within normal values, averaging (3.867).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a major bank
Industry MajorBanks
Advertisement